Text Registration
Copyright Title
Bioengineering Innovative Solutions for Cancer
Status
Published
on 23 Jan 2020
Year of Creation
2019
Copyright Claimant
Elsevier Inc
Registration Number
TX0008989302
on 23 Jan 2020Copyright Summary
The U.S. Copyright record (Registration Number: TX0008989302) dated 23 Jan 2020, pertains to an electronic file (eService) titled "Bioengineering Innovative Solutions for Cancer" created in 2019. The copyright holder is Elsevier Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Elsevier Inc.
Application Details
Registration Number
TX0008989302
Registration Date
1/23/2020
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Book, 377 p
First Publication Nation
United States
ISBN
9780128138861
Preexisting Material
permissioned materials
Notes
Rights Note: permissions@elsevier.com
Local Copyright Note: C.O. correspondenceBasis for Registration: Collective Work
Material Matter Claimed Note: text
Statements
Application Title Statement: Bioengineering Innovative Solutions for Cancer
Author Statement: Sylvain Ladame Domicile: United Kingdom Citizenship: United Kingdom Authorship: text
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.